Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2ccPA in Knee Osteoarthritis
NCT05807529Phase 2Active, not recruiting
- Sponsor
- Orient EuroPharma
- Start
- Nov 2022
- Primary completion
- Dec 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of 2-carba-cyclic phosphatidic acid in osteoarthritis (OA), sponsored by Orient EuroPharma. Started Nov 2022; status: active, not recruiting.
02
Drugs
2-carba-cyclic phosphatidic acid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT05807529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05807529.